ImmunoGen Switzerland GmbH
Pharmaceuticals · Cham, Zug
ImmunoGen Switzerland GmbH is a Swiss pharmaceuticals company based in Cham, Canton of Zug, listed in the Swiss commercial register since 2022 (UID CHE-291.025.414). It is a subsidiary of AbbVie AG.
Board members & signatories
- Shu How — Geschäftsführer
- Michele Ravara — Vorsitzender der Geschäftsführung
- ImmunoGen Europe Limited (5592199) — Gesellschafter
Registered purpose
Der Zweck der Gesellschaft ist der Erwerb, das Verwalten, das Halten und Veräussern von Immaterialgüterrechten und die Entwicklung, Herstellung und Vermarktung von pharmazeutischen Erzeugnissen, inklusive die Antikörper-Wirkstoff-Konjugate Mirvetuximab Soravtansine und Pivekimab Sunirine. Die Gesellschaft kann Beteiligungen an Gesellschaften aller Art in der Schweiz und im Ausland erwerben, halten…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What ImmunoGen Switzerland does
OFFERING
ImmunoGen Switzerland GmbH, now part of AbbVie, focuses on developing therapies for cancer treatment. The company is involved in a dynamic oncology pipeline aimed at improving treatment outcomes for patients.
Unlock the full analysis →Similar companies
- Immunovant Sciences GmbH — Biotechnology · Basel
- Vaximm AG — Pharmaceuticals · Basel
- ImmunOs Therapeutics AG — Pharmaceuticals · Schlieren
- Engimmune Therapeutics AG — Biotechnology · Allschwil
- NovImmune SA — Biotechnology · Plan-les-Ouates
- Leman Biotech Lausanne AG — Pharmaceuticals · Lausanne
Find every pharmaceuticals company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned pharmaceuticals companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime